Altered expression of membrane inhibitors of complement in human gastric epithelium during Helicobacter-associated gastritis

Histopathology

Volumn 33, Issue 6, 1998, Pages 554-560

  Sasaki, M ^a   Joh, T ^a   Tada, T ^a   Okada, N ^a   Yokoyama, Y ^a   Itoh, M ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

DAF; Gastric mucosa; H. pylori; HRF20; MCP

Indexed keywords

CD59 ANTIGEN; COMPLEMENT INHIBITOR; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN;

ADULT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; FEMALE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH MUCOSA;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0031699639     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00539.x     Document Type: Article

References (20)

1. Davitz MA. Decay-accelerating factor (DAF): a review of its function and structure. Acta Med. Scand. Suppl. 1986; 715; 111-121.
2. Kinoshita T. Biology of complement: the overture. Immunol. Today 1991; 12; 291-295.
3. Nicholson-Weller A, Burge J, Fearon DT et al. Isolaion of a human erythrocyte membrane glycoprotein with decay-acceleratinu. activity for C3 convertases of the complement system. J. Immunol. 1982; 129; 184-189.
4. Fujita T, Inoue T, Ogawa K et al. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. J. Exp. Med. 1987; 166; 1221-1228.
5. Okada N, Harada R, Fujita T et al. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int. Immunol. 1989; 1; 205-208.
6. Rollins SA, Sims PJ. The complement-inhibitory activation of CDS9 resides in its capacity to block incorporation of C9 into membrane C5b-9. J. Immunol. 1990; 144; 3478-3483.
7. Seya T, Turner JR, Atkinson JP. Purification and characterisation of a membrain protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 1986; 163; 837-855.
8. Nose M, Katoh M, Okada N et al. Tissue distribution of HKF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo. Immunology 1990; 70; 145-149.
9. McNearney T, Ballard L, Seya T et al. Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J. Clin. Invest 1989; 84; 538-545.
10. Medof ME, Walter EI, Rutgers JL et al. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluid. J. Exp Med. 1987; 165; 848-864.
11. Koretz K, Bruderlein S, Henne C et al. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br. J. Cancer 1992; 66; 810-814.
12. Koretz K, Bruderlein S, Henne C et al. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium. Br. J. Cancer 1993; 68; 926-931.
13. Inoue H, Mizuno M, Uesu T et al. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma und cancer. Acta Med. Okayama 1994; 48; 271-277.
14. Uesu T, Mizuno M, Inoue H et al. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab. Invest. 1995; 72; 587-591.
15. Davitz MA, Low MG, Nussenzweig V. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol.-specific phospholipase C (PIPLC). J. Exp. Med. 1986; 163; 1150-1161.
16. Dixon MF, Genta RM, Yardley JU et al. Classification and grading of gastritis. The updated Sydney system. Am. J. Surg. Pathol. 1996; 20; 1161-1181.
17. Medof ME, Walter EI, Roberts WL et al. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry 1986; 25; 6740-6747.
18. Moutabarrik A, Nakanishi I, Namiki M et al. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46 (MCP), CD55 (DAF), and CD59 on human vascular endothelial cells. Cytokine Res. 1993; 12; 167-172.
19. Bjorge L, Jensen TS, Matre R. Characterization of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on human colonic adenocarcinoma cell line. Cancer Immunol. Immunother. 1996; 42; 185-192.
20. Peek RM Jr, Miller GG, Tham KT et al. Heightened inflammatory response and cytokine expression in vivo to cagA Helicobactor pylori stains. Lab. Invest. 1995; 73; 760-770.